Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Close this folderOpening ceremony
View the documentMr Xiaoyu Zheng, Director-General, State Drug Administration, China
View the documentDr Yasuhiro Suzuki, Executive Director, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland
View the documentDr Eng-Kiong Yeoh, Secretary for Health and Welfare, Hong Kong Special Administrative Region, China
View the documentProfessor Alfred Hildebrandt, Chair of the Ninth ICDRA, Germany
View the documentDr Margaret Chan, Chair of the Tenth ICDRA Director of Health, Hong Kong Special Administrative Region, China
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Open this folder and view contentsAntimicrobial resistance - new initiatives
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Dr Yasuhiro Suzuki, Executive Director, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland

The goal of this conference is to promote collaboration among national drug regulatory authorities by facilitating the exchange of information and fostering discussion of issues of international relevance, such as access to quality pharmaceuticals and harmonization of standards and clinical trials. From WHO’s perspective, this conference acts as a network and platform through which we can promote global consensus on important issues. I am pleased to announce that the Director-General of WHO has decided to designate access to quality medicines as a priority in the 2004-2005 Programme Budget of WHO.

I would like to mention some of the challenges we are all facing today. We are facing globalization, with increased cross-border trade; we see counterfeit drugs marketed within and between countries; and we see constant advances in science and technology. How can regulatory authorities keep pace with the changes? All of these issues will be covered in discussions over the next four days.

I am totally convinced that, by working together, we can overcome these challenges and contribute to the welfare of the world’s population by ensuring access to quality medicine.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014